SC

Sai Chand Yarra

Active Director Director DIN 09097496
DIN 09097496 First appointment Mar 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2021
Shareholding value Locked Premium profile

About Sai Chand Yarra

Sai Chand Yarra has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Spyro Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09097496
Primary Designation Director
First Appointment 09 Mar 2021
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Director 09 Mar 2021 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Spyro Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sai Chand Yarra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sai Chand Yarra

Sai Chand Yarra has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Spyro Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Sai Chand Yarra is associated with 1 company as Director.

Sai Chand Yarra has expertise in General Business.

Sai Chand Yarra has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available